Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Columbus Acquisition Corp Announces the Separate Trading of its Ordinary Shares and Rights, Commencing on March 17, 2025
-
Brera Holdings and Global Law Firm Clifford Chance Release Report on Multi-Team Ownership of Women’s Soccer
-
Announcing Becklar Monitoring: SMART Critical Event Monitoring
-
Baker Hughes Announces Dates for First-quarter 2025 Earnings Release and Webcast
-
AllSurplus Conducts Second Sale in China for Global Energy Leader, Expanding Circular Economy Footprint
-
Southwire Taps Plug Power, Inc. to Advance Carbon Reduction from the Supply Chain
-
Redwood to Host Second Cross-Border Logistics Council Amid Trade Uncertainty
-
Oxbridge / SurancePlus to Attend Digital Asset Summit 2025 in New York
-
FDA Study May Proceed Notice Received for Phase 2 Trial of TPST-1495 for the Treatment of Familial Adenomatous Polyposis (FAP)
-
zSpace Set to Join Russell 2000® and 3000® Indexes
-
Adagene to Present at 11th Annual Immuno-Oncology 360⁰ Summit
-
Montara Therapeutics Closes $20M Oversubscribed Seed Expansion, Appoints Troy Wilson as Chairman of the Board
-
SUPERIOR GROUP OF COMPANIES TO PARTICIPATE IN THE SIDOTI MARCH INVESTOR CONFERENCE
-
PDS Biotech Announces FDA Clearance of IND Application for Combination of Versamune® MUC1 and PDS01ADC to Treat Metastatic Colorectal Cancer
-
OP Mortgage Bank's Report by the Board of Directors and Financial Statements as well as Corporate Governance Statement for 2024 published
-
OP Corporate Bank plc’s Report by the Board of Directors, Financial Statements and Corporate Governance Statement for 2024 published
-
OP Financial Group's Annual Report 2024 has been published
-
Municipality Finance will redeem early notes issued under its MTN programme
-
BIO-key Partners with California Ed Tech JPA to Make its Identity and Access Management Solutions Available to 195 Member Institutions Serving Over 2.6M Students
-
COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product
-
Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform
-
Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform
-
ZenaTech Expands ZenaDrone Team by 35 Engineers and Technicians to Meet Drone Production Manufacturing Capacity
-
Alliance Witan PLC - Net Asset Value
-
Advanced Flower Capital Inc. Announces Financial Results for Fourth Quarter and Full Year 2024
-
Altisource Announces Fourth Quarter and Full Year 2024 Financial Results
-
FTI Consulting Adds Regulatory Risk and Compliance Expert Michael Herde to Financial Services Offering
-
PDD Holdings to Report Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025
-
Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
-
Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
-
Rett Syndrome Research Trust Appoints Amy Gilliland to its Board of Trustees
-
Notice of Knight Therapeutics' Fourth Quarter and Year End 2024 Results Conference Call
-
Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process
-
MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process
-
GD Culture Group Limited Announces Closing of Private Placement
-
Dragonfly Energy to Report Fourth Quarter and Full Year 2024 Financial and Operational Results on March 24, 2025
-
Creative Realities, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call Information
-
Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
-
Notice to the Annual General Meeting of Verkkokauppa.com Oyj
-
TenderAlpha Launches Daily Macro Government Contracting Data Feed for Real-Time Public Spending Insights
-
Form 8.3 - Primary Health Properties
-
Trading in GN Store Nord shares by board members, executives and associated persons
-
Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement
-
XRP News: SEC vs. Ripple Case Nears Conclusion as XRP’s First Launchpad, BlocScale, Gains Massive Momentum – Join $BLOC Seed Sale
-
Jeffs’ Brands Achieves an Important Milestone Towards Completion of Fort’s Proposed Merger with a Publicly Traded Company – Receives Valuation Report of Fort for Approximately US$11.6 - US$14.2
-
VITAS® Healthcare Regional Medical Director Earns AAHPM Fellow Status
-
Jeffs’ Brands Achieves an Important Milestone Towards Completion of Fort’s Proposed Merger with a Publicly Traded Company – Receives Valuation Report of Fort for Approximately US$11.6 - US$14.2
-
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update
-
Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update
-
Construction contract in Estonia (Rail Baltica main line Tallinn-Pärnu section)
